Literature DB >> 11303628

Health-related quality of life three years after diagnosis of head and neck cancer--a longitudinal study.

E Hammerlid1, E Silander, L Hörnestam, M Sullivan.   

Abstract

PURPOSE: To examine health-related quality of life (HRQL) of all head and neck cancer patients from diagnosis until 3 years later and to analyze its dependence on tumor site and other patient characteristics. SUBJECTS AND METHODS: Two hundred thirty-two patients (mean age 61 years; 70% men) were included and followed with clinical measures and mailed standardized HRQL questionnaires (The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30), the EORTC QLQ-Head and Neck Cancer module (QLQ-H&N35), and the Hospital Anxiety and Depression Scale (HADS).
RESULTS: After 3 years 66% of the patients were alive and 88% of these completed the study. The HRQL was worse during treatment and returned slowly thereafter to pretreatment values with few exceptions. After 3 years the best improvement was found for mental distress, followed by a significant global quality of life improvement and reduced pain compared with diagnosis. A significant deterioration was found for problems with dry mouth, senses, and teeth, as well as for opening the mouth wide (ie, they seemed to be related to the treatment given). There were few significant improvements between the 1- and 3-year follow-ups. Depression and physical functioning at diagnosis were independent predictors for global quality of life at 3 years. Patients who died during the study had a worse HRQL at diagnosis compared with patients completing the study. Patients with advanced disease (stage III + IV) scored worse than patients with small tumors for most of the HRQL domains. These differences increased over time. Few differences were found relating to gender and age. The pharyngeal cancer group scored worse compared with the other tumor sites, and these patients would probably benefit from a rehabilitation program right from diagnosis, including treatment for malnutrition and pain.
CONCLUSIONS: The largest HRQL changes for head and neck cancer patients are seen within the first year after diagnosis, with a significant deterioration just after finishing treatment. Thereafter, most of the variables return to pretreatment values. The significant problems with dry mouth, senses, and teeth after treatment are constant over time.

Entities:  

Mesh:

Year:  2001        PMID: 11303628     DOI: 10.1002/1097-0347(200102)23:2<113::aid-hed1006>3.0.co;2-w

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  69 in total

1.  A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.

Authors:  Wei Xiao; Zhixiong Lin; Wuzhe Zhang; Mei Li; Vincent W C Wu
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

2.  Smoking status and symptom burden in surgical head and neck cancer patients.

Authors:  Katherine R Sterba; Elizabeth Garrett-Mayer; Matthew J Carpenter; Janet A Tooze; Jeanne L Hatcher; Christopher Sullivan; Lee Anne Tetrick; Graham W Warren; Terrence A Day; Anthony J Alberg; Kathryn E Weaver
Journal:  Laryngoscope       Date:  2016-07-09       Impact factor: 3.325

3.  Psychological impact of thyroid surgery on patients with well-differentiated papillary thyroid cancer.

Authors:  Tae-Yon Sung; Yong-Wook Shin; Kee-Hyun Nam; Hang-Seok Chang; Yumie Rhee; Cheong Soo Park; Woong Youn Chung
Journal:  Qual Life Res       Date:  2011-03-20       Impact factor: 4.147

4.  Superficial parotid lobe-sparing delineation approach: a better method of dose optimization to protect the parotid gland in intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  H B Zhang; X Lu; S M Huang; L Wang; C Zhao; W X Xia; S W Li; F L Wang; Y L Zhu; X Guo; Y Q Xiang
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

5.  Sexual and relationship health among survivors of oropharyngeal or oral cavity squamous cell carcinoma.

Authors:  Gypsyamber D'Souza; Hilary A Robbins
Journal:  Cancer       Date:  2017-02-14       Impact factor: 6.860

6.  Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.

Authors:  Christina P C Sim; Joseph Wee; Ying Xu; Yin-Bun Cheung; Yoke-Lim Soong; David J Manton
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

Review 7.  Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review.

Authors:  Susanne Singer; Juan Ignacio Arraras; Wei-Chu Chie; Sheila E Fisher; Razvan Galalae; Eva Hammerlid; Ourania Nicolatou-Galitis; Claudia Schmalz; Irma Verdonck-de Leeuw; Eva Gamper; Judith Keszte; Dirk Hofmeister
Journal:  Qual Life Res       Date:  2012-11-28       Impact factor: 4.147

8.  One-year effect of a nurse-led psychosocial intervention on depressive symptoms in patients with head and neck cancer: a randomized controlled trial.

Authors:  Ingeborg C van der Meulen; Anne M May; Wynand J G Ros; Miriam Oosterom; Gert-Jan Hordijk; Ron Koole; J Rob J de Leeuw
Journal:  Oncologist       Date:  2013-02-21

9.  Identification of Baseline Characteristics Associated With Development of Depression Among Patients With Head and Neck Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Aru Panwar; Katherine Rieke; William J Burke; Harlan Sayles; William M Lydiatt
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

10.  Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapy.

Authors:  Joel B Epstein; Diana J Wilkie; Dena J Fischer; Young-Ok Kim; Dana Villines
Journal:  Head Neck Oncol       Date:  2009-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.